BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31299413)

  • 1. Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.
    Vijay V; Miller R; Vue GS; Pezeshkian MB; Maywood M; Ast AM; Drusbosky LM; Pompeu Y; Salgado AD; Lipten SD; Geddes T; Blenc AM; Ge Y; Ostrov DA; Cogle CR; Madlambayan GJ
    Leuk Res; 2019 Sep; 84():106180. PubMed ID: 31299413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
    Okamoto S; Miyano K; Kitakaze K; Kato H; Yamauchi A; Kajikawa M; Itsumi M; Kawai C; Kuribayashi F
    Biochem Biophys Res Commun; 2022 Jan; 587():78-84. PubMed ID: 34872003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition.
    Drusbosky L; Gars E; Trujillo A; McGee C; Meacham A; Wise E; Scott EW; Cogle CR
    Leuk Res; 2015 Sep; 39(9):984-9. PubMed ID: 26189107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
    Zhang Y; Guo H; Zhang Z; Lu W; Zhu J; Shi J
    Exp Cell Res; 2022 Jun; 415(1):113112. PubMed ID: 35346671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia in the vascular niche.
    Cogle CR; Bosse RC; Brewer T; Migdady Y; Shirzad R; Kampen KR; Saki N
    Cancer Lett; 2016 Oct; 380(2):552-560. PubMed ID: 25963886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
    Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
    Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia.
    Piya S; Andreeff M; Borthakur G
    Autophagy; 2017 Jan; 13(1):214-215. PubMed ID: 27797294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 Facilitates Acute Myeloid Leukemia Chemoresistance via Mitofusin 1-Mediated Mitochondrial Fusion.
    Hou D; Zheng X; Cai D; You R; Liu J; Wang X; Liao X; Tan M; Lin L; Wang J; Zhang S; Huang H
    Mol Cancer Res; 2023 Dec; 21(12):1366-1378. PubMed ID: 37698549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
    Shah K; Mirza S; Desai U; Jain N; Rawal R
    Anticancer Agents Med Chem; 2016; 16(1):128-35. PubMed ID: 26278546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.
    Li P; Diab S; Yu M; Adams J; Islam S; Basnet SK; Albrecht H; Milne R; Wang S
    Oncotarget; 2016 Aug; 7(35):56811-56825. PubMed ID: 27462781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
    Schneider C; Oellerich T; Baldauf HM; Schwarz SM; Thomas D; Flick R; Bohnenberger H; Kaderali L; Stegmann L; Cremer A; Martin M; Lohmeyer J; Michaelis M; Hornung V; Schliemann C; Berdel WE; Hartmann W; Wardelmann E; Comoglio F; Hansmann ML; Yakunin AF; Geisslinger G; Ströbel P; Ferreirós N; Serve H; Keppler OT; Cinatl J
    Nat Med; 2017 Feb; 23(2):250-255. PubMed ID: 27991919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
    Hu N; Chen L; Wang C; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108720. PubMed ID: 30970520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitizing AML cells by targeting bone marrow endothelial cells.
    Bosse RC; Wasserstrom B; Meacham A; Wise E; Drusbosky L; Walter GA; Chaplin DJ; Siemann DW; Purich DL; Cogle CR
    Exp Hematol; 2016 May; 44(5):363-377.e5. PubMed ID: 26898708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance.
    Hu X; Mei S; Meng W; Xue S; Jiang L; Yang Y; Hui L; Chen Y; Guan MX
    Cancer Lett; 2018 Jul; 425():1-12. PubMed ID: 29574276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.